UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities and Exchange Act of 1934
Therapeutic Solutions International, Inc. |
(Name of Issuer) |
|
Common |
(Title of Class of Securities) |
|
883378 101 |
(CUSIP Number) |
|
January 22, 2013 |
(Date of Event Which Requires Filing of this Statement) |
Check the appropriate box to designate the rule pursuant to which this is filed: X . Rule 13d-1(b) . Rule 13d-1(c) . Rule 13d-1(d) |
*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. |
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). |
Page 1 of 4 pages
CUSIP NO. 883378101 |
| Page 2 of 4 Pages | |||||
|
|
| |||||
1 | NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (entities only) Tad Mailander | ||||||
|
| ||||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) . (b) . | ||||||
|
| ||||||
3 | SEC USE ONLY | ||||||
|
| ||||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION United States | ||||||
NUMBER OF | 5 | SOLE VOTING POWER 7,526,200 | |||||
SHARES | |||||||
BENEFICIALLY OWNED BY EACH REPORTING | 6 | SHARED VOTING POWER 0 | |||||
PERSON |
|
| |||||
WITH | 7 | SOLE DISPOSITIVE POWER 7,526,200 | |||||
|
|
| |||||
| 8 | SHARED DISPOSITIVE POWER 0 | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 7,526,200
| ||||||
|
| ||||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES .
| ||||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 9% | ||||||
|
| ||||||
12 | TYPE OF REPORTING PERSON IN | ||||||
2
Item 1(a)
The name of the issuer is Therapeutic Solutions International, Inc.
Item 1(b)
The address of the Issuer's principal executive offices is: 4093 Oceanside Boulevard, Suite B
Oceanside, California 92056
Tel. Number: 760-295-7208
Item 2(a)
The name of reporting person is: Tad Mailander
Item 2(b)
The residence address of the Reporting Person is: 835 5th Avenue, San Diego, CA 92101
Item 2(c)
The citizenship of the reporting Person is: United States
Item 2(d)
The title of the class of securities is: Common
Item 2(e)
The CUSIP Number of the securities is: 883378 101
Item 3
This statement is not filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c).
Item 4
Ownership:
The Reporting Person’s is the beneficial owner of 7,526,200 representing 9% of the class of securities.
The Reporting Person has:
(i)
sole power to vote or to direct the vote of: 7,526,200 shares
(ii)
shared power to vote or to direct the vote of: 0 shares
(iii)
sole power to dispose or to direct the disposition of: 7,526,200 shares
(iv)
shared power to dispose or to direct the disposition of: 0 shares
Item 5
Ownership of Five Percent or Less of Class: Not applicable
Item 6
Ownership of More than Five Percent on Behalf of another Person: Not applicable
3
Item 7
Identification and Classification of the Subsidiary which Acquired the Security Being Reported on By the Parent Holding Company: Not applicable
Item 8
Identification and Classification of Members of the Group: Not applicable
Item 9
Notice of Dissolution of Group: Not applicable
Item 10
Certification:
By signing below, I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
April 30, 2013
Date
/s/ Tad Mailander
Signature
Tad Mailander
Name
4